Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer
- 19 May 2018
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (7) , 1877-1883
Abstract
The aim of this work was to evaluate the expression of the cancer stem cell (CSC) markers CD44, ALDH1 and p75NTR in the ultraviolet-induced lesions actinic cheilitis (AC) and lip squamous cell carcinoma (LSCC), and to correlate it with p53 expression.Keywords
Funding Information
- FAPESP (08/54606-9)
This publication has 29 references indexed in Scilit:
- ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakiaOncology Letters, 2016
- Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53Cell Death & Disease, 2015
- Mucin1 expression in focal epidermal dysplasia of actinic keratosis2015
- p53: The barrier to cancer stem cell formationFEBS Letters, 2014
- Role of p75 neurotrophin receptor in stem cell biology: more than just a markerCellular and Molecular Life Sciences, 2014
- Normal stem cells and cancer stem cells: similar and differentSeminars in Cancer Biology, 2010
- Nuclear Localization of the p75 Neurotrophin Receptor Intracellular DomainJournal of Biological Chemistry, 2010
- Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 ExpressionCell, 2008
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsCancer Research, 2008
- Identification and expansion of the tumorigenic lung cancer stem cell populationCell Death & Differentiation, 2007